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ReviewTargeting Transcription
to the Neuromuscular Synapse
by the fundamental nuclei (for references to papers dem-
onstrating compartmentalized transcription, see Duclert
and Changeux, 1995, and Sanes and Lichtman, 1999).
Laurent Schaeffer,2,3
Alban de Kerchove d’Exaerde,2,4
and Jean-Pierre Changeux1
Laboratoire de Neurobiologie Mole´culaire It is of considerable interest to understand the molecular
mechanisms that control the normal development of thisCNRS URA 2182 “Re´cepteurs et Cognition”
Institut Pasteur highly compartmentalized gene expression in vivo, in
particular the precise role played by neural factors in25 rue du Dr Roux
75724 Paris Cedex 15 the control of synapse-specific gene expression.
Two distinct mechanisms contribute to the regulationFrance
of AChR gene transcription. On one hand, nerve-evoked
electrical activity in the muscle fiber represses transcrip-
tion of AChR genes in the extra junctional area. On the
other hand, trophic factors such as the acetylcholineSummary
receptor-inducing activity (ARIA/heregulin /neu-differ-
entiation factor/neuregulin 1) and also, indirectly, agrinConcomitant with innervation, genes coding for com-
(for review, see Sanes and Lichtman, 1999, and refer-ponents of the neuromuscular junction become exclu-
ences therein) selectively enhance transcription of AChRsively expressed in subsynaptic nuclei. A six-base pair
genes in the postsynaptic domain. This review will pri-element, the N box, can confer synapse-specific tran-
marily focus on this later aspect of transcriptional regu-scription to the acetylcholine nicotinic receptor  and
lation at the neuromuscular synapse. subunit, utrophin, and acetylcholine esterase genes.
N box-dependent synaptic expression is stimulated
Identification of the N Boxby the nerve-derived signal agrin and the trophic factor
A model proposed about 15 years ago (Changeux et al.,neuregulin, which triggers the MAPK and JNK signal-
1987) for the compartmentalized transcription of AChRing pathways, to ultimately allow activation by the N
genes postulates a correspondence between synapse-box binding Ets transcription factor GABP.
specific signals and defined promoter elements (and
transcription factors) within synapse-specific genes, to-
The neuromuscular junction (NMJ) in vertebrates is a gether with parallel elements (and transcription factors)
favorable model system to investigate the molecular responding to electrical activity in extrajunctional areas.
mechanisms of synapse formation and plasticity. The To identify the promoter elements involved in the tar-
acetylcholine nicotinic receptor (AChR) is a transmem- geting of transcription to the junctional domain, an in
brane ligand-gated ion channel composed of four sub- vivo direct DNA injection technique was used. System-
units , , , and  assembled into an heteropentamer atic mutagenesis of the AChR  (Koike et al., 1995) and
[2]. Concomitant with innervation, the AChR be-  (Duclert et al., 1996) subunit promoters resulted in the
comes highly concentrated at the level of the postsynap- identification of a single six-base pair element named
tic membrane. After birth, an  subunit replaces the  the N box, required for synapse-specific expression of
subunit to form the adult type of AChR, which possesses the reporter gene. In addition, when fused to a minimal
different ion channel properties. Many other molecules promoter, the N box specifically increased synaptic ex-
are also concentrated at the endplate. Among those pression of a reporter gene. Yet, the extent of the expres-
present are the basal lamina proteins neuregulins, agrin, sion specificity was lower than in the context of the
and acetylcholine esterase, the membrane receptors for AChR  or  promoters, suggesting the existence of
agrin and neuregulins and the cytoskeletal associated cooperativity with other promoter sites (Koike et al.,
proteins 43 K/rapsyn and utrophin (for review, see Sanes 1995; see below).
and Lichtman, 1999). Under this highly specialized su- The importance of the N box has been confirmed in
pramacromolecular assembly lie a few specialized nu- transgenic mice where mutations in the N box of the
clei referred to as “fundamental nuclei” characterized AChR  promoter completely abolished the expression
by a clear chromatin and hypertrophied nucleoli. of a reporter gene in adult innervated muscle. In these
The AChR is an excellent marker of synaptic differenti- mice, expression of the transgene in denervated muscle
ation. At early stages of development, AChR genes are was not affected, suggesting that the N box is necessary
expressed all along the embryonic myotube, whereas for synaptic expression but is not involved in the repres-
soon after a motor nerve terminal has contacted the sion of synaptic genes expression by nerve-evoked
myotube, AChR genes become exclusively expressed electrical activity (Fromm and Burden, 1998).
A direct demonstration of the physiological impor-
1 Correspondence: changeux@pasteur.fr tance of the N box in vivo was brought about by the
2 These authors contributed equally to this work. discovery that a point mutation in the N box of the AChR
3 Present address: Laboratoire de Biologie Mole´culaire et Cellulaire,
 subunit promoter causes congenital myasthenia (Nich-
ENS Lyon, UMR 5663, 46 alle´e d’Italie, 69364 Lyon cedex 07, France.
ols et al., 1999; Ohno et al., 1999). These congenital4 Present address: Laboratory of Neurophysiology, Department of
myasthenic patients carry mutations in the AChR  pro-Neuroscience, CP 601, Universite´ Libre de Bruxelles, School of Med-
ecine, 808 route de Lennik, 1070 Brussels, Belgium. moter that precisely correspond to the experimental mu-
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tations known to abolish synaptic targeting of the AChR deed, the inactivation of the Ets factor ER81 by homolo-
gous recombination abolishes the formation of func- subunit gene in mouse (Schaeffer et al., 1998; Nichols
tional connections between a group of muscle sensoryet al., 1999). AChR expression was examined in one
neurons and motor neurons (Arber et al., 2000).of these patients, and muscle biopsies were found to
Although GABP  expression is stronger in subsynap-contain reduced levels of  subunit mRNA (Nichols et
tic nuclei, GABP subunit genes mRNAs are present inal., 1999).
both the synaptic and extrasynaptic muscle compart-The control of transcription by the N box is not limited
ments (Schaeffer et al., 1998). At least four alternativeto the AChR  and  subunit genes. The utrophin gene
(or complementary) mechanisms may restrict activationpromoter contains an N box that is essential for the
by GABP to the postsynaptic domain in response to asynaptic expression of utrophin (Gramolini et al., 1999;
synaptic “neurotrophic” signal. First, since the shortestKhurana et al., 1999). Moreover, the acetylcholine ester-
spliced form of GABP  does not contain the putativease gene promoter contains four N boxes. One among
transcriptional activation domain, differential expres-these, located in the first intron, is crucial for the synaptic
sion of two GABP splice variants could restrict the tran-expression of acetylcholine esterase (Chan et al., 1999).
scriptionally active forms of GABP to subsynaptic nuclei.The N box is thus a critical element in targeting the
This possibility could be tested by examining the distri-transcription of several major synaptic genes to the mo-
bution and subcellular localisation of the GABP  and tor endplate.
polypeptides in muscle. A second plausible mechanism
could be that in the extra synaptic area one or bothThe N Box Recruits the Ets Class Transcription
GABP subunits are sequestered into the cytoplasm and/Factor GABP
or are degraded more rapidly than in the synaptic zone.Adult mouse muscle, as well as cultured myotubes, con-
A third mechanism could involve an Ets factor with re-tains a factor (or factors) that specifically interacts with
pressor activity such as ERF that binds the N box inthe N box sequence. One factor was purified from cul-
extra-synaptic nuclei instead of GABP. However, no Ntured muscle cells on a DNA affinity column and com-
box binding activity other than GABP is detectable inprises a heterodimer composed of 58 and 43 kDa poly-
muscle extracts, although more than 99% of the nucleipeptides corresponding to the Ets-related transcription
they originate from are extra-synaptic. Alternatively,factor GABP (Schaeffer et al., 1998; Khurana et al., 1999).
GABP itself could act as a repressor in the extra synapticThis finding is consistent with the fact that the N box
nuclei. Such a dual activator/repressor function has in-contains the GGAA sequence characteristic of the bind-
deed already been shown for GABP (Genuario and Perry,ing sites for the transcription factors belonging to the
1996).Ets family. The 58 kDa GABP  subunit binds DNA
A fourth mechanism that could be invoked is the spe-through its Ets domain. The 43 kDa GABP  subunit
cific upregulation of the GABP transactivation potentialdoes not contact DNA but contains ankyrin repeats that
in subsynaptic nuclei by the signaling pathways trig-mediate its interaction with GABP , thus strengthening
gered by a synaptic trophic factor. Two such factors,the interaction of the  subunit with DNA (Batchelor et
capable of stimulating AChR expression, were respec-
al., 1998).
tively described several years ago: CGRP (calcitonin
GABP  is encoded by two closely related, alterna-
gene related peptide) (Fontaine et al., 1986) and ARIA
tively spliced genes, GABP 1 and GABP 2. Each of
(acetylcholine receptor inducing activity) (Falls et al.,
these genes yields two alternatively spliced products. 1993). CGRP is present in the motor nerve ending and
GABP 2 expression could not be detected in muscle enhances AChR genes expression in cultured myotubes
or cultured myotubes, and the relative level of expres- (Fontaine et al., 1986). Yet, knockout mice for CGRP
sion of the alternatively spliced forms of GABP 1 in do not show major changes in the morphology of the
muscle has not been investigated (Schaeffer et al., 1998; NMJ (Lu et al., 1999; Salmon et al., 1999). The closely
Fromm and Burden, 1998). The binding of the GABP related CGRP, which is produced by a different gene,
/1 complex to the N box results in transcriptional might compensate for the loss of CGRP. However, the
activation from the AChR  and  promoters. Indeed, endplates from CGRP knockout mice did not reveal
antisense oligonucleotides directed toward GABP 1 or significant CGRP-like immunoreactivity. ARIA was ini-
dominant-negative mutants of GABP  or  block N tially purified from chick brain on the basis of its ability
box-mediated transcriptional activation from the AChR to stimulate AChR expression in cultured myotubes
 and  promoters in cultured myotubes (Schaeffer et (Falls et al., 1993). ARIA is also known as heregulin ,
al., 1998). neu-differentiation factor, or neuregulin  and encodes
Briguet and Ruegg (2000) have shown that a GABP  a 42 kDa protein belonging to the neuregulin 1 family of
dominant-negative mutant that blocks activation by the EGF-like polypeptides, a group of 14 proteins that are
N box in cultured myotubes also blocks agrin-induced generated from the alternative splicing of a single gene
postsynaptic differentiation in vivo (also see the further (see Burden, 1998). Genetic inactivation of a subset of
section on agrin). In addition, expression and aggrega- neuregulin isoforms (the Ig-like domain containing form)
tion of synaptic proteins encoded by the AChR  gene, is lethal before any neuromuscular junction is formed.
and by the N box containing genes utrophin and acetyl- However, analysis of heterozygous mutants revealed
choline esterase, is significantly reduced at the ectopic that these animals exhibit signs of congenital myasthe-
synapses. This provides a direct evidence that in vivo, nia and show a 50% decrease in the RNA coding for
as in cultured myotubes, GABP mediates the activation AChRs (Sandrock et al., 1997). In addition, in vivo muscle
of synaptic genes. The involvement of Ets transcription injection of a neuregulin expression vector stimulates
the expression of a reporter gene controlled by the syn-factors in synapse formation is not unprecedented. In-
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apse specific utrophin promoter (Gramolini et al., 1999). compartmentalization of AChR genes expression could
be observed in the mutant animals. But whether thisThese results support the idea that, in vivo, neuregulins
contribute to AChR genes upregulation at the NMJ. effect can be directly attributed to the absence of the
erbB2 or 3 gene products or to the absence of terminal
Schwann cells and early nerve withdrawal is not clearNeuregulins and Their Receptors
(Morris et al., 1999; Woldeyesus et al., 1999). NMJ wereSince the N box is the key promoter element of several
nevertheless recently examined before retraction of thesynapse-specific genes, and since neuregulin is the best
motor axon terminal in erbB2-deficient embryos, and itcandidate factor to elicit synapse-specific transcription,
was found that the formation of junctional folds wasit is anticipated that the N box and GABP are the down-
significantly impaired (Lin et al., 2000). This suggests astream targets of the signaling pathways triggered by
role of erbB2 in postsynaptic development indepen-neuregulins. In addition, Ets transcription factors are
dently of its presynaptic function.classical targets of the MAP kinase signaling pathway
Thus, although the question remains open, neuregu-through which neuregulins mediate their action. Finally,
lins still appear as likely candidate trophic factor for thegene expression regulation by neuregulins via Ets tran-
activation of synaptic genes.scription factors is not unprecedented. In breast cancer
cells, upregulation of the Ets factor PEA3 transcriptional
activity by neuregulins, via the ERK and JNK signaling A Role for Agrin and MuSK in the Control
of Synaptic Gene Expressionpathways, has indeed been reported (O’Hagan and Has-
sell, 1998). Neuregulins are produced both by the nerve and the
muscle, but have been proposed to activate transcrip-Neuregulins receptors belong to the same family as
the EGF receptor: the erbB family of tyrosine kinase tion exclusively in subsynaptic nuclei. Consistent with
this, neuregulins are only detectable in the basal laminareceptors. Neuregulins can bind to various dimers of
erbB subunits (erbB2/erbB3, erbB2/erbB4, erbB3/ at the endplate, most probably because of the localiza-
tion of agrin and MuSK clustering activity. There is aerbB4, and erbB4/erbB4) and cause their phosphoryla-
tion. In innervated skeletal muscle, erbB2, erbB3, and growing body of evidence suggesting that neuregulins
are in fact acting as secondary signals, downstream oferbB4 are clustered at the NMJ (Altiok et al., 1995; re-
viewed in Burden, 1998). The distribution of erbB sub- neural agrin and MuSK, which may be the primary sig-
nals in the process of activating subsynaptic tran-units at the rat NMJ has recently been reexamined more
accurately using confocal microscopy, and it appears scription.
Agrin is a 210 kDa heparan sulfate glycoprotein, whichthat if both erbB2 and erbB4 are localized in the muscle
postsynaptic membrane, erbB3 is only detectable in was initially identified as a component of the Torpedo
electric organ extracellular matrix that stimulates AChRpresynaptic terminal Schwann cells (Trinidad et al.,
2000). The functional muscle receptor for neuregulins clustering via the 43K/rapsyn protein, in muscle cell cul-
tures (Fallon et al., 1985). Several forms of agrin arein rat thus seems to be either the erbB2/erbB4 hetero-
dimer, or an erbB4 homodimer, or both. The localization produced through alternative splicing of the agrin gene.
The most potent isoform of agrin in AChR clustering isof erbB3 in the presynaptic rather than postsynaptic
compartment facilitates the interpretation of two intri- produced by the nerve, the muscle isoforms being less
active. As shown by gene inactivation in mice and furtherguing observations made by Merlie and colleagues
(Moscoso et al., 1995). First, preferential synaptic ex- experiments in cultured myotubes, the functional agrin
receptor most probably includes the tyrosine kinase re-pression of synaptic genes in mouse embryos takes
place before erbB3 is detectable at the NMJ. Second, ceptor MuSK (muscle specific kinase). Until recently,
agrin was believed to act in a dedicated manner to pro-in rapsyn-deficient mice, synaptic transcription is not
affected, although erbB3 is not concentrated anymore mote the clustering of AChRs at the NMJ, without effects
on transcriptional regulation. Yet, in knockout mice defi-at the NMJ. In both cases, terminal Schwann cells ap-
pear to be absent—in the first case because synaptic cient for either the neural form of agrin or MuSK, sub-
synaptic compartmentalized expression is respectivelytranscription occurs prior to NMJ maturation, and in the
second case because presynaptic maturation is severly severely affected or abolished (reviewed in Sanes and
Lichtman, 1999). Normal subsynaptic transcription thusimpaired in the mutant mice.
The knockout of several erbB subunit genes in mice requires the presence of both neural agrin and MuSK.
In addition, in vivo ectopic expression of agrin or of ahas not provided substantial evidence in favor of a role of
neuregulin receptors in activating synaptic transcription constitutively active form of MuSK in muscle is sufficient
to cause the formation of a functional postsynaptic ap-because of a probable redundancy among erbB sub-
units and a decrease in Schwann cell survival, which paratus, together with the upregulation of genes nor-
mally restricted to synapses (Meier et al., 1998; Jonesleads secondary to early nerve withdrawal. The erbB2
and 4 genes have been inactivated by homologous re- et al., 1999).
In fact, although clearly related, agrin and MuSK seemcombination, but mutant animals die at embryonic day
10.5 of development because of a lack of cardiac trabec- to have distinct roles in the initiation of synapse-specific
transcription. In very recent reports (Lin et al., 2001;ulae. The erbB2 knockout was next genetically rescued
in the heart, thus allowing the embryos to develop up Yang et al., 2001), early AChR distribution was investi-
gated in mutant mice, with either noninnervated musclesto birth. In these mice, as well as in erbB3 knockout
mice, neuromuscular junctions did not show striking or/and deficient for the agrin, or MuSK, gene. The au-
thors made the surprising observation that AChR clus-difference in function, ultrastructure, or composition.
However, ectopic AChR clusters and reduced synaptic tering and compartmentalized transcription takes places
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at the right place in aneural muscles, thus demonstrating to neuregulins have been investigated in muscle cells.
Neuregulin treatment results in the phosphorylation ofthat the muscle is somehow prepatterned for synapse
localization. In addition, MuSK, but not agrin, is required their erbB tyrosine kinase receptors and in the subse-
quent recruitment and activation of both ras and PI3to initiate AChR clustering and local expression at em-
bryonic day (E) 14.5 in aneural mutants. Neural agrin is kinase. ErbB receptors also interact with another kinase,
the cyclin-dependent kinase cdk5, and its activator p35.nevertheless required for sustained AChR expression
and clustering, since in agrin-deficient mice, localized These two proteins are concentrated at the neuromus-
cular junction and cdk5 activity is both stimulated by,AChR transcription is barely detectable at E18.5, al-
though it was present at E14.5 (Lin et al., 2001). The and necessary for, erbB activation by neuregulins (Fu
et al., 2001). Downstream Ras activation results in themost probable explanation to this phenomenon is that
localized expression and transcription is initiated in activation of the MAP kinase and JNK pathways. Blocking
the MAP kinase (or only ERK2) or JNK pathways is suffi-muscle by MuSK activation via a still unknown mecha-
nism. Nerve-derived agrin would then stabilize this state, cient to block neuregulin dependent activation (re-
viewed in Burden, 1998; Si et al., 1999). In vivo, muscleprotecting innervated clusters from the action of a still
uncharacterized neural signal, perhaps electrical activ- injection of dominant-negative mutants of three key
components of the MAP kinase cascade—namely ras,ity, promoting AChR clusters disruption (for review, see
Ferns and Carbonetto, 2001). raf, and MEK—inhibits the expression of a reporter gene
driven by the AChR  gene promoter (Si et al., 1999).The upregulation of synaptic gene expression in aneu-
ral muscles, or at agrin-induced ectopic synapses (Meier The same group reported that AChR genes activation
by neuregulins may include additional steps. In C2C12et al., 1998; Jones et al., 1999; Lin et al., 2001; Yang et
al., 2001), shows further that neuregulins of neural origin myotubes, the stimulation of AChR  gene expression
by neuregulins is a delayed response, which requiresare not required for synapse-specific transcriptional ac-
tivation, since they are most probably not present in protein synthesis and involves the expression of the
immediate early genes c-Jun and c-fos. These authorseither case. Moreover, specific inactivation of the neu-
regulin-1 gene in motor and sensory neurons by homolo- also made the intriguing observation that a 60 s expo-
sure of myotubes to neuregulins is sufficient to triggergous recombination does not prevent the onset of AChR
gene-specific synaptic expression (Yang et al., 2001). a delayed increase in AChR  mRNA level 5 hr later, and
this expression reaches its maximum level 24 hr afterConsistently, in vitro, agrin increases the expression of
the AChR  subunit gene in cultured myotubes grown brief stimulation. In addition, the increase of c-Jun and
c-fos expression, as well as of ERK and JNK activities,on a laminin substrate, in the absence of exogenous
neuregulins (Jones et al., 1996). Two observations sug- is transient (Si et al., 1996, 1999). These observations
raise the issue of the nature of the long-lasting eventsgest that agrin and MuSK activate synaptic transcrip-
tion via the neuregulin pathway. First, in cultured myo- that are triggered by a brief application of neuregulin
that manifests itself in the activation of immediate earlytubes, a dominant-negative mutant of erbB2 blocks
agrin elicited transcriptional activation (Meier et al., genes, yet only 5 hr later translates into an increase in
AChR subunit mRNA expression.1998). Second, in vivo, ectopic expression of agrin in
muscle induces the clustering of all postsynaptic pro- Although there is a general agreement about the piv-
otal role played by the MAP kinases, substantial discrep-teins including neuregulins and their receptor(s) (Meier
et al., 1998; Jones et al., 1999). When considered to- ancies persist concerning the possible role of the PI3
kinase. In chick primary myotubes, blockade of PI3 ki-gether, the most plausible interpretation of these results
is that MuSK activation induces the clustering of erbB nase by wortmannin, or of the downstream p70S6 kinase
by rapamycin, increases the level of AChR  subunitreceptors and of neuregulins, originating from either the
nerve or the muscle, and that subsequent activation of mRNA, suggesting that the PI3 and p70S6 kinases re-
press the activation by neuregulin (Altiok et al., 1997).downstream intracellular signaling pathways ultimately
leads to transcriptional activation of synaptic genes. In mouse Sol 8 cells, however, opposite results have
been obtained (Tansey et al., 1996). In addition, the ex-Close examination of the agrin/MuSK and neuregu-
lins/erbB receptors distribution in the postsynaptic pression of a constitutively active form of the PI3 kinase
could mimic the effect of neuregulin on the reportermembrane shows that agrin and MUSK are localized in
the postsynaptic primary gutters together with the AChR gene expression driven by the AChR  subunit promoter.
Finally, in mouse C2C12 myotubes, the PI3 kinase path-and rapsyn, whereas neuregulins/erbB receptors are
present in the depth of the secondary junctional folds. way appears not to affect neuregulin stimulation of
AChR gene expression (Si and Mei, 1999). These dis-This implies that neuregulin and erbB receptor clustering
induced by agrin and MuSK does not result from a direct crepancies may reflect differences in species and/or cell
lines. Alternatively, they could result from differences ininteraction (Trinidad et al., 2000).
chromatin context or from the involvement of posttran-
scriptional regulation (in some cases, the endogenousSignaling Pathways Involved in Synaptic
mRNA levels were measured, whereas in others reporterActivation of Transcription
genes were used).Neuregulins and their receptors are involved in the con-
trol of a wide variety of mitogenic and differentiation
processes. They can therefore influence a complex net- Neuregulins and the N Box
Several lines of evidence argue that transcriptional acti-work of intracellular signaling pathways, which is likely
to vary with cell type and the expression of distinct erbB vation by neuregulins is mediated by GABP and the N
box. Indeed, in myotube cultures, neuregulin-mediatedsubunits. The signaling pathways activated in response
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Figure 1. A Model for the Targeting of Transcription to the Neuromuscular Junction.
In subsynaptic nuclei, transcriptional activation of synaptic genes is initiated by activation of the tyrosine kinase receptor MuSK (muscle
specific kinase), either as a result of autoactivation, or of the binding of the basal lamina protein agrin. Neuregulins (ARIA) and their muscle
receptor, probably composed of a combination of erbB2 and erbB4, then accumulate in the basal lamina and the plasma membrane,
respectively. Activation of neuregulin receptors synergizes with cdk5 and triggers both the MAP kinase and JNK pathways via Ras. This leads
to the transient activation of the immediate early genes c-Jun and c-fos expression and to the phosphorylation of the Ets-related transcription
factor GABP that will activate transcription of synapse specific genes via binding to the N box.
In extra synaptic nuclei, transcription of the AChR , , , and  genes is severely reduced as a consequence of the AChR clustering induced
by agrin, via the rapsyn/43 K protein, and of the AChR activation by acetylcholine released by the synaptic button. Indeed, nerve-evoked
electrical activity in the muscle fiber triggers calcium entry into the cytoplasm, which activates serine/threonine kinases that will ultimately
lead to the inhibition of the bHLH myogenic factors and thus of the AChR genes , , , and  transcription (for review, see Sanes and
Lichtman, 1999).
ACh, acetylcholine; ARIA, acetylcholine receptor inducing activity; GABP, GA binding protein; DGC, dystroglycan glycoprotein complex; N,
N box; E, E box, binding site for the myogenic factors; P, other positive promoter elements.
activation of utrophin, AChR , or AChR  promoters prevents agrin-induced activation of the AChR  pro-
moter (Briguet and Ruegg, 2000). Finally, overexpres-requires an intact N box. (Fromm and Burden, 1998;
Sapru et al., 1998; Schaeffer et al.,1998; Khurana et sion of wild-type GABP in muscle in vivo mimics the
action of neuregulins on reporter gene expressional.,1999). Similar results have been obtained in vivo with
the utrophin gene promoter after the stimulation of re- through the utrophin gene promoter (Gramolini et al.,
1999).porter gene expression by neuregulins (Gramolini et
al.,1999). The finding that expression of the utrophin gene can
be modulated by neuregulins and GABP is of potentialThe role of GABP as an intermediary in neuregulin
action has been addressed using dominant-negative medical interest. Utrophin is a dystrophin-related pro-
tein present only at the NMJ, where it contributes tomutants of GABP and Ets-2. Such mutants, of either
GABP subunits, prevents activation of the AChR  and  the architecture of the postsynaptic apparatus. When
expressed along mdx dystrophic muscle fibers, utrophinsubunits promoters by neuregulin in cultured myotubes
(Schaeffer et al., 1998). Overexpression of the DNA bind- can compensate functionally for the lack of dystrophin
(Tinsley et al., 1998). Therefore, the finding that neuregu-ing domain of Ets2, which blocks Ets factors binding to
the N box, has a similar effect (Sapru et al., 1998). The lin and GABP stimulate utrophin gene expression in vivo
may have implications for the treatment of DuchenneGABP  mutant has also been expressed in vivo and
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muscular dystrophy (DMD). These proteins may repre- gated sodium channels). This clustering process in-
volves the aggregation of neuregulins and their erbBsent accessible targets for pharmacological agents de-
signed to upregulate utrophin gene expression in DMD receptor(s) in the synaptic basal lamina and plasma
membrane, respectively.patients (Gramolini et al., 1999; Khurana et al., 1999).
Studies on the molecular mechanisms that account for Neuregulins stimulate cdk5 activity and the autophos-
phorylation of erbB receptors, which then activate Rasthe targeting of gene transcription to the synapse is
therefore beginning to open new avenues in the treat- to trigger the two kinases Raf-1 and MEK (MAPK kinase)
kinase (MEKK). This results in the rapid activation of thement and prevention of neuromuscular disorders.
If the involvement of the N box and GABP in neuregu- ERK and JNK kinases, possibly followed by activation
of the immediate early gene c-Jun expression and thelins response is becoming clear, many of the mechanis-
tic details of transcriptional activation by neuregulins phosphorylation of both c-Jun and GABP. Phosphory-
lated GABP and c-Jun, either sequentially or in concertvia GABP are still obscure. Neuregulins exert several
effects on GABP in cultured myotubes. They cause a (through a still-unknown mechanism), activate transcrip-
tion of the synaptic genes via GABP binding to the N box.2-fold increase in GABP  levels, and they enhance the
phosphorylation of both GABP subunits by MAP kinases Agrin and neuregulins are expressed in the brain, and
studies conducted on transcriptional regulation at the(Schaeffer et al., 1998; Khurana et al., 1999). The neureg-
ulin-elicited increase in GABP  level may account for NMJ could be relevant for central synapses. For in-
stance, neuregulins are involved in the induction of neu-the stronger expression of GABP  transcripts in synap-
tic nuclei (Schaeffer et al., 1998). Neuregulin-induced ronal nicotinic acetylcholine receptors in developing
chick sympathetic ganglia (Yang et al., 1998). Moreover,phosphorylation of GABP does not affect its DNA bind-
ing activity, but it may regulate the stability of the protein in cortical neuron cultures, agrin, whose neuronal recep-
tor is still unknown, has been reported to induce immedi-or its ability to activate transcription via recruitment of
other transcription factors, cofactors, or by interactions ate early gene expression, and GABA receptors cluster-
ing (Serpinskaya et al., 1999). Finally, agrin is alsowith the basal transcriptional machinery.
The potential recruitment of transcription factors by involved in immune synapses regulation since it is an
inducer of lipid raft aggregation (Khan et al., 2001).GABP is particularly attractive in the light of the finding
that c-Jun is required for AChR  subunit stimulation by
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